HIV Drugs In Development

The Latest

What Is an Investigational HIV Drug?

This fact sheet explains what investigational HIV drugs are, how trials are conducted, and how access can be obtained through clinical trials and expanded access programs.

By AIDSinfo

I want to take ART once a year

Hi doctor. My CD4 count is 784,viral load is 1286 and I don't want to take ARVs I only want that one we take yearly as am afraid I will forget to take them sometimes as am always busy at work

By Benjamin Young, M.D., Ph.D.

What Is a Therapeutic HIV Vaccine?

Unlike a preventive HIV vaccine, a therapeutic HIV vaccine is designed to improve the body's immune response to HIV in people who are already infected with the virus. In the future, these vaccines could eliminate HIV from the body, or improve the bod...

By AIDSinfo

PrEP Trials: The Benefits -- and Challenges -- of Seeking Community Input

Last fall, community activists voiced concerns over the roll out of studies on Descovy (TAF/FTC) as pre-exposure prophylaxis (PrEP) without adequately involving community advisors.

By Jennifer Johnson Avril

Long-Acting Injectable HIV Treatment Moves Closer to Reality

Long-acting injectable treatment takes another step closer to being a real-world option for people living with HIV, with new study results presented at IAS 2017.

By Warren Tong

Surprise FDA Approval of Generic Truvada Is a 'Wakeup Call' for Activists

The surprise approval of generic Truvada (tenofovir disoproxil fumarate and emtricitabine) by the U.S. Food and Drug Administration (FDA) on June 9 left patients, advocates and doctors scrambling to understand exactly when the generic will become ava...

By Sony Salzman

TIB Drug

Dear Doctor, Thanks for your kind answers. I would like now to know whether you have reviewed any new information regarding TIB as an alternative to ART. Basically they say its a functional cure as its inhibits infection of the CD cells. It is said r...

By Benjamin Young, M.D., Ph.D.

Ibalizumab: First Long-Acting HIV Treatment Available Now Via Expanded Access

Ibalizumab, a drug that works against multi-drug-resistant HIV, is now available via the manufacturer's expanded access program.

By Nelson Vergel, B.S.Ch.E., M.B.A.

Down the Road: New Drugs, New Treatment Strategies and Other Changes Coming Your Way

What's on the horizon for HIV treatment? Here's a look at the HIV drug pipeline from 2017 to 2021.

By Positively Aware

Real or Not? HIV Cure in Animals Using CRISPR Gene Editing

You may have heard about the "HIV cure with gene editing in animals" story. Here's some help making sense of the story, including what's true or not, and what to get excited about.

By Warren Tong